OpenBench

Curated by Signal

AI-based virtual drug screening technology for researchers

Overview

AI-based virtual drug screening technology for researchers. The company has developed a small molecule drug discovery tool that enables reachers to predict molecular properties for drug discovery. It has features for data engineering, data curation, and more.

Key facts

Founded: 2019
Headquarters: San Francisco, United States
Stage: Sign up to view
Industry: Health Technology

Business model

5 products and services: Sign up to view
Commercial model: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Animal Cancer Dx
Developer of cancer in-vitro diagnostic test for dogs
Health TechnologyRaleigh, United States
Global Q
Provider of quality management system solutions for life sciences manufacturers
Health TechnologyChelmsford, United States
Avisena
Cloud based SaaS platform for revenue cycle and practiice management solutions.
Health TechnologyMiami, United States

About OpenBench

What does OpenBench do?

AI-based virtual drug screening technology for researchers.

Where is OpenBench headquartered?

OpenBench is headquartered in San Francisco, United States.

When was OpenBench founded?

OpenBench was founded in 2019.

Which sector is OpenBench in?

OpenBench operates in Health Technology.

Who are OpenBench's competitors?

Companies similar to OpenBench include Animal Cancer Dx, Global Q, and Avisena.